The neuro-protective effect of antenatal magnesium sulfate on very preterm infants has been
demonstrated in good-quality randomised controlled trials and meta-analyses. Magnesium …

Background Magnesium sulphate is currently recommended for neuroprotection of preterm
infants for women at risk of preterm birth at less than 30 weeks' gestation, based on high …

METHODS OF STUDY SELECTION: Randomized controlled trials comparing magnesium
sulfate with placebo/other treatment in patients at risk of preterm delivery were evaluated for …

Antenatal administration of magnesium sulfate is an important part of the neuroprotective
strategy for preterm infants. Strong evidence from five randomized controlled trials and five …

Very preterm infants have high rates of neurological impairments and disabilities. These
rates have not diminished as the survival rates have improved. Basic science research …

Despite improvements in perinatal care, preterm birth still occurs regularly and the
associated brain injury and adverse neurological outcomes remain a persistent challenge …

Antenatal magnesium sulfate and neuroprotection : Current Opinion in Pediatrics Antenatal
magnesium sulfate and neuroprotection : Current Opinion in Pediatrics Log in or Register …

OBJECTIVE: To systematically review rates of neurologic outcomes reported in childhood for
the preterm fetus exposed to antenatal magnesium sulfate. DATA SOURCES: We searched …

Preterm infants are at increased risk for serious, lifelong neurologic abnormalities such as
cerebral palsy. 1, 2 As the survival of preterm infants has improved with advances in …

Objective The objective is to provide guidelines for the use of antenatal magnesium sulphate
for fetal neuroprotection of the preterm infant. Options Antenatal magnesium sulphate …